The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 21, 2024
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Leading USA based genetic testing brand officially enters the Indian market
Demonstrate significant bleed reduction in hemophilia A and B
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
The companies plan to start a pivotal Phase 3 trial in the coming months
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
Subscribe To Our Newsletter & Stay Updated
